Expertise in
7
conditions

Franck Durif

Clermont-ferrand, FR 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
7
conditions
Clermont-ferrand, FR 
OverviewLocationsClinical Research

Overview

Franck Durif practices in Clermont-ferrand, France. Mr. Durif is highly rated in 7 conditions, according to our data. His top areas of expertise are Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, Deep Brain Stimulation, and Sacral Nerve Stimulation.

His clinical research consists of co-authoring 127 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Clermont-ferrand, France
Other Locations
Strasbourg, France
Marseille, France
Bâtiment Babinski, Consultation De Pathologie Neuro Musculaire, 47, Boulevard De L'Hôpital, 75651 Paris Cedex 13, Paris, 75651, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Enrollment Status: Recruiting
Publish Date: May 28, 2024
Intervention Type: Device
Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control Subjects
Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control Subjects
Enrollment Status: Recruiting
Publish Date: January 29, 2024
Intervention Type: Other
Study Phase: Not Applicable
Study of Pimavanserin Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease
Study of Pimavanserin Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease
Enrollment Status: Completed
Publish Date: January 01, 2025
Intervention Type: Drug, Procedure, Behavioral
Study Drug: Pimavanserin
Study Phase: Phase 2
A Dose-Ranging Study of the Efficacy, Safety, and Pharmacokinetics of Deferiprone Delayed Release Tablets in Patients With Parkinson's Disease
A Dose-Ranging Study of the Efficacy, Safety, and Pharmacokinetics of Deferiprone Delayed Release Tablets in Patients With Parkinson's Disease
Enrollment Status: Completed
Publish Date: April 10, 2024
Intervention Type: Drug
Study Phase: Phase 2
French Validation Study of a New Scale for Neuropsychiatric Fluctuations in Parkinson Disease
French Validation Study of a New Scale for Neuropsychiatric Fluctuations in Parkinson Disease
Enrollment Status: Completed
Publish Date: August 02, 2023
Intervention Type: Other
Study Phase: Not Applicable
Circadian Character of Food Compulsions and Impulses Control Disorders in Parkinsonian Patients With and Without Resting Leg Syndrome
Circadian Character of Food Compulsions and Impulses Control Disorders in Parkinsonian Patients With and Without Resting Leg Syndrome
Enrollment Status: Completed
Publish Date: July 10, 2023
Intervention Type: Behavioral
Study Phase: Not Applicable
Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor by a Multi-center, Randomized, Double-Blind, Parallel-group, Placebo-controlled Study
Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor by a Multi-center, Randomized, Double-Blind, Parallel-group, Placebo-controlled Study
Enrollment Status: Completed
Publish Date: December 12, 2022
Intervention Type: Drug
Study Drug: BOTOX
Study Phase: Phase 3
Predictive Factors for Therapeutic Response of Subthalamic Stimulation on Quality of Live in Parkinson's Disease
Predictive Factors for Therapeutic Response of Subthalamic Stimulation on Quality of Live in Parkinson's Disease
Enrollment Status: Active_not_recruiting
Publish Date: November 07, 2022
Intervention Type: Other
Impact of Amantadine on L-DOPA-induced Dyskinesia in Early Parkinson's Disease: a Placebo-controlled Randomized Study (the PREMANDYSK Study)
Impact of Amantadine on L-DOPA-induced Dyskinesia in Early Parkinson's Disease: a Placebo-controlled Randomized Study (the PREMANDYSK Study)
Enrollment Status: Completed
Publish Date: February 05, 2021
Intervention Type: Drug
Study Phase: Phase 2
Treatment of Severe and Resistant Obsessive-compulsive Disorder by High-frequency Stimulation of the Ventral Striatum and the Subthalamic Nucleus
Treatment of Severe and Resistant Obsessive-compulsive Disorder by High-frequency Stimulation of the Ventral Striatum and the Subthalamic Nucleus
Enrollment Status: Completed
Publish Date: February 06, 2020
Intervention Type: Procedure
Study Phase: Phase 3
Exploration of the Reward System by Functional MRI in Parkinson's Disease Patients With and Without REM Sleep Behavior Disorder
Exploration of the Reward System by Functional MRI in Parkinson's Disease Patients With and Without REM Sleep Behavior Disorder
Enrollment Status: Completed
Publish Date: March 16, 2018
Intervention Type: Device
Study Phase: Not Applicable
Study of Efficacy and Acceptability of Tetrabenazine in the Late Dyskinetic Syndrome With Neuroleptics: A Randomized, Parallel Group, Double-blind Placebo Controlled Multicentre Trial
Study of Efficacy and Acceptability of Tetrabenazine in the Late Dyskinetic Syndrome With Neuroleptics: A Randomized, Parallel Group, Double-blind Placebo Controlled Multicentre Trial
Enrollment Status: Completed
Publish Date: September 12, 2017
Intervention Type: Drug
Study Phase: Phase 3
Double-Blind Randomized Placebo-Controlled Cross-Over Phase IIa Trial to Evaluate Efficacy of CVXL-0107 on Parkinson-Related Symptoms and Levodopa-Induced Dyskinesia in Advanced Parkinson's Disease Patients Using a Levodopa Challenge Test
Double-Blind Randomized Placebo-Controlled Cross-Over Phase IIa Trial to Evaluate Efficacy of CVXL-0107 on Parkinson-Related Symptoms and Levodopa-Induced Dyskinesia in Advanced Parkinson's Disease Patients Using a Levodopa Challenge Test
Enrollment Status: Completed
Publish Date: July 24, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 11 Less Clinical Trials

127 Total Publications

Disease Progression in Multiple System Atrophy: The ASPIRE Multi-Modal Biomarker Study.
Disease Progression in Multiple System Atrophy: The ASPIRE Multi-Modal Biomarker Study.
Journal: Annals of neurology
Published: March 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Durif's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile